For millions of women around the world, ovarian cancer remains one of the most challenging diagnoses to hear. Known as a stealthy illness, it often hides inside the abdomen until it has reached advanced stages. Even when doctors perform surgery to remove a tumor and prescribe standard chemotherapy, stubborn cancer cells can linger behind.
To make matters harder, delivering medicine directly to those hidden cells, and checking whether a treatment is actually working, has required invasive, repeated procedures. Now, a team of biomedical engineers and cancer specialists has developed an innovative solution. Researchers from the University of Galway, alongside collaborators from the Massachusetts Institute of Technology (MIT), the University of Minnesota, and the Wyss Institute, have designed a flexible, smart medical implant capable of fighting ovarian cancer directly from the inside.
How the Device Works
When treating ovarian cancer, doctors primarily target the peritoneal cavity—the fluid-filled space surrounding the abdominal organs. This area is where ovarian tumors most commonly spread and re-emerge. The new device is built from a soft, biologically safe material that folds smoothly to match the internal contours of a patient’s body. Instead of forcing patients to undergo multiple invasive surgeries to deliver medicine, the implant features a special porous surface connected to a small external access port located just under the skin.
This simple connection acts like a secure door:
- Targeted Delivery: Doctors can easily inject living cell therapies or specialized drugs into the port.
- Gentle Release: The medicine slowly diffuses across the implant’s porous membrane, placing the therapy right where the cancer cells hide.
- Refillable System: Medical teams can safely top up the medicine as often as needed over time.
A Two-Way Street: Treating and Tracking at the Same Time What makes this invention truly exciting is that it does not just give medicine,it also gathers valuable information. In the past, checking whether a tumor was responding to therapy required complex scans or exploratory procedures. This smart implant changes the dynamic by creating a direct, two-way communication line with the peritoneal cavity. By applying gentle suction through the same external port, doctors can draw tiny samples of fluid from around the tumor. Analyzing this fluid gives clinicians a real-time snapshot of what is happening inside the body. They can observe how well immune cells are fighting, track the tumor’s reaction, and immediately adapt the patient’s treatment plan.
Early Results and What Lies Ahead
In preclinical laboratory studies, the flexible implant remained fully operational inside the body for up to 70 days with zero implant-related complications. More importantly, it showed significantly better control over tumor growth compared to traditional therapy methods. Scientists envision inserting the device during a patient’s initial surgery to remove tumor tissue. Once in place, the implant can continuously attack any lingering cancer cells and monitor for early signs of recurrence. While further safety tests are required before clinical trial testing in human patients, the engineering team believes this technology could also adapt to treat other abdominal cancers, such as stomach cancer.
By bringing localized medicine directly to the site of disease and granting doctors a window into the body, this bioengineered device brings personalized cancer care one step closer to reality.
Reference
Dolan, E., Geller, M., et al. (2026). In situ delivery and real-time monitoring of peritoneal cancer therapies using a flexible bio-implantable device. Device, 4(8), Article S2666-9986(26)00157-2. https://doi.org/10.1016/j.device.2026.00157
